BV
Bharath Varma Nadimpalli
About Bharath Varma Nadimpalli
Data last updated:
Bharath Varma Nadimpalli is a Director at Clrna Therapeutics Private Limited (since 2024) and Director at Cloudminds Consultancy (Opc) Private Limited (since 2023). The companies operate in Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹1.9 Lakh; the largest is Clrna Therapeutics Private Limited at ₹1.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Oct 2024 | 2024 | ₹1.7 Lakh (FY 2025) | Active | |
| Director | 24 Jul 2023 | 2023 | ₹22,676 (FY 2025) | Active |
Board colleagues of Bharath Varma Nadimpalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raj Kumar Kunaparaju | 00670448 | Clrna Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharath Varma Nadimpalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharath Varma Nadimpalli
Bharath Varma Nadimpalli currently holds 2 directorships: Clrna Therapeutics Private Limited (Director, since 14 Oct 2024, revenue ₹1.7 Lakh (FY 2025)); Cloudminds Consultancy (Opc) Private Limited (Director, since 24 Jul 2023, revenue ₹22,676 (FY 2025)).
Bharath Varma Nadimpalli was first appointed on 24 Jul 2023 as Director at Cloudminds Consultancy (Opc) Private Limited. The most recent appointment on record is 14 Oct 2024 at Clrna Therapeutics Private Limited.
The 2 current companies of Bharath Varma Nadimpalli that report revenue have a combined latest revenue of ₹1.9 Lakh: Clrna Therapeutics Private Limited ₹1.7 Lakh (FY 2025); Cloudminds Consultancy (Opc) Private Limited ₹22,676 (FY 2025).
The current boards of Bharath Varma Nadimpalli's companies include Raj Kumar Kunaparaju (Clrna Therapeutics Private Limited).